Both exogenous and endogenous cannabinoids can allosterically modulate glycine receptors (GlyRs). However, little is known about the molecular basis of cannabinoid-GlyR interactions. Here we report that sustained incubation with the endocannabinoid anandamide (AEA) substantially increased the amplitude of glycine-activated current in both rat cultured spinal neurons and in HEK-293 cells expressing human ␣1, rat ␣2 and ␣3 GlyRs. While the ␣1 and ␣3 subunits were highly sensitive to AEA-induced potentiation, the ␣2 subunit was relatively insensitive to AEA. Switching a serine at 296 and 307 in the TM3 (transmembrane domain 3) of the ␣1 and ␣3 subunits with an alanine (A) at the equivalent position in the ␣2 subunit converted the ␣1/␣3 AEA-sensitive receptors to sensitivity resembling that of ␣2. The S296 residue is also critical for exogenous cannabinoid-induced potentiation of I Gly . The magnitude of AEA potentiation decreased with removal of either the hydroxyl or oxygen groups on AEA. While desoxy-AEA was significantly less efficacious in potentiating I Gly , desoxy-AEA inhibited potentiation produced by both ⌬ 9 -tetrahydrocannabinol (THC), a major psychoactive component of marijuana, and AEA. Similarly, didesoxy-THC, a modified THC with removal of both hydroxyl/oxygen groups, did not affect I Gly when applied alone but inhibited the potentiation of I Gly induced by AEA and THC. These findings suggest that exogenous and endogenous cannabinoids potentiate GlyRs via a hydrogen bonding-like interaction. Such a specific interaction likely stems from a common molecular basis involving the S296 residue in the TM3 of the ␣1 and ␣3 subunits.
Introduction
Emerging evidence has suggested that glycine receptors (GlyRs) are an important target for actions of exogenous and endogenous cannabinoids in the CNS (Zhang and Xiong, 2009) . A number of recent studies have shown that cannabinoids can potentiate GlyR-mediated responses in various neurons and in cells expressing recombinant GlyRs via CB 1 and CB 2 independent mechanisms (Hejazi et al., 2006; Yang et al., 2008; Ahrens et al., 2009; Delaney et al., 2010; Xiong et al., 2011; Yevenes and Zeilhofer, 2011a) . In addition to modulating GlyRs, both exogenous and endogenous cannabinoids have been shown to allosterically modulate all other members of the Cys-loop ligand-gated ion channels (LGICs) including serotonin type 3A (5-HT 3A ), neuronal nicotinic acetylcholine (nACh) and GABA A receptors (Fan, 1995; Barann et al., 2002; Oz et al., 2004; Hejazi et al., 2006; Xiong et al., 2008; Sigel et al., 2011) . There is strong evidence to suggest that some of the cannabinoid-induced behavioral effects are independent of CB 1 receptors. The endocannabinoid anandamide (AEA) stimulates GTP␥S binding in brain membranes isolated from mice lacking CB 1 receptors, and this effect is not altered by CB 1 and CB 2 antagonists (Di Marzo et al., 2000) . ⌬ 9 -tetrahydrocannabinol (THC), the principle psychoactive component of marijuana, and AEA-induced analgesic effects in the tail flick test (for THC) and hot-plate test (for AEA) remain intact in mice with depleted CB 1 receptors (CB 1 Ϫ/Ϫ ) (Zimmer et al., 1999; Di Marzo et al., 2000) or both CB 1 and CB 2 receptors (Rácz et al., 2008) . A recent study from our laboratory has suggested that exogenous and synthetic cannabinoid potentiation of GlyRs contributes to psychoactive and nonpsychoactive cannabinoidinduced analgesic effect in the tail flick reflex in mice (Xiong et al., 2011) .
The GlyRs are involved in several physiological and pathological processes including neuromotor activity, antinociception, muscle relaxation, anxiety and reward mechanisms (Lynch, 2009) . The GlyRs are formed as pentameric homomeric chloride channels of ␣1, ␣2, ␣3 and ␣4 subunits or as ␣␤ heteromeric functional channels (Lynch, 2004) . Each GlyR subunit is composed of an extracellular domain, four transmembrane domains (TMs) and a large cytoplasmic domain between TM3 and TM4. There is strong evidence showing that distinct sites located in these domains mediate functional modulation of GlyRs by different allosteric modulators (Lobo and Harris, 2005; Harris et al., 2008; Foadi et al., 2010; Xiong et al., 2011; Yevenes and Zeilhofer, 2011a) . A recent study has revealed a serine at position 296 in the TM3 of GlyR as a distinct site to critically regulate THC-induced potentiation of GlyR (Xiong et al., 2011) . However, little is known about the molecular mechanisms underlying endocannabinoid AEA potentiation of GlyRs. Here we report that the ␣1, ␣2 and ␣3 GlyR subunits are differentially sensitive to the AEA-induced potentiation of I Gly . The S296 residue already implicated in THC potentiation of ␣1 GlyR function contributes to the differential sensitivity of different GlyR subunits to sustained AEA application. We have also provided evidence to suggest that exogenous and endogenous cannabinoids interact with GlyRs through a common molecular basis.
Materials and Methods

Cultured spinal neurons
Animals were treated and handled according to NIH guidelines. Postnatal day 0 rats of either sex were killed by cervical dislocation. The spinal cords were removed from three to five rats. The tissue, which was chopped into small pieces, was incubated with 5 ml of papain solution (Worthington, 20 U/ml) at 37°C for 40 min. The tissue was washed and triturated through a 9 inch glass Pasteur pipette with the tip fire polished to an opening of 0.7-0.9 mm diameter. The cell suspension was centrifuged at 120 ϫ g for 5 min and the supernatants were discarded. Spinal neurons were resuspended and plated, at a concentration of 300,000 cells/ml, into 35 mm tissue culture dishes coated with poly-D-lysine (0.1 mg/ml). The neuronal feeding medium consisted of 90% minimum essential medium, 10% heat-inactivated fetal bovine serum and a mixture of nutrient supplements (Invitrogen). New medium was added every 3 d. Cells were cultured for at least 10 d and washed with normal external solution (see below) for 30 min before starting the electrophysiological experiments.
HEK-293 cell transfection and electrophysiological recording
HEK-293 cells were cultured as described previously (Hu et al., 2006) . The plasmid cDNAs coding for the wild-type and mutant GlyR subunits and human 5-HT 3A receptors (5-HT 3A Rs) were transfected using the SuperFect Transfection Kit (Qiagen). Electrophysiological recordings were performed 2 d after transfection. HEK-293 cells were treated with 0.25% (w/v) Trypsin and 0.53 mM EDTA 2 h before recording. The HEK-293 cells were lifted and continuously superfused with a solution containing (in mM): 140 NaCl, 5 KCl, 1.8 CaCl 2 , 1.2 MgCl 2 , 5 glucose, and 10 HEPES ( pH 7.4 with NaOH; ϳ340 mOsm with sucrose). Patch pipettes (3-5 M⍀) were filled with the intracellular solution that contained the following (in mM): 120 CsCl, 4 MgCl 2 , 10 EGTA, 10 HEPES, 0.5 Na-GTP, and 2 Mg-ATP ( pH 7.2 with CsOH, ϳ280 mOsm). Membrane currents were recorded in the whole-cell configuration using an Axopatch 200B amplifier (Axon) at 20Ϫ22°C. Cells were held at Ϫ60 mV unless otherwise indicated. Data were acquired using pClamp 9.2 software (Molecular Devices). Data were filtered at 1 kHz and digitized at 2 kHz. Bath solutions were applied through 3 barrel square glass tubing (Warner Instrument) with a tip diameter of ϳ700 m. Drugs were applied using a Warner fast-step steppermotor driven system. The solution exchange time constants were ϳ4 ms for an open pipette tip and 4 -12 ms for whole-cell recording.
Site-directed mutagenesis
Point-mutations of the human ␣1 GlyR, rat ␣2 and ␣3 GlyR subunits, and human 5-HT 3A R were introduced using a QuikChange SiteDirected Mutagenesis Kit (Stratagene). The authenticity of the DNA sequence through the mutation sites was confirmed by doublestranded DNA sequencing using a CEQ 8000 Genetic Analysis System (Beckman Coulter, Inc).
Molecular modeling and simulations
␣1 GlyR and 5-HT 3A R were modeled with SWISS-MODEL (Guex and Peitsch, 1997; Schwede et al., 2003; Arnold et al., 2006) , using a homologous structure (PDB code: 3ehz, chain A) as a template. Five ␣1 GlyR or 5-HT 3A R chains were superimposed on the five chains of the nicotinic acetylcholine receptor (PDB code: 2bg9) to create a pentamer conformation. CHARMM (Brooks et al., 1983 (Brooks et al., , 2009 ) package was used to perform minimization and simulation. For efficient simulation, the N-terminal extracellular domains (1-252) were removed. THC and AEA molecules were placed in the membrane region near TM3. The C-terminal transmembrane helix bound together with the AEA molecules was minimized and simulated for 2 ns with the self-guided Langevin dynamics method Brooks, 2003, 2011) to search for stable conformations.
Drugs
Most chemicals including glycine (Gly) were from Sigma. Solutions were prepared on the day of the experiment. Agonists and other compounds were diluted either directly in the bath solution or dissolved in ethanol before further dilution. The maximal concentration of ethanol in the bath solution was Ͻ8 mM, which, when applied alone, did not affect either I Gly or AEA-induced potentiation of I Gly . The maximal concentra-
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Gly Gly Gly Gly tion of THC and AEA used was 30 M because the compounds were difficult to keep in solution at concentrations Ͼ30 M.
Chemical synthesis
Desoxyanandamide. LiAlH 4 of 0.14 ml at 1 M in THF, 0.14 ml) was added dropwise to 5 ml of anandamide (25 mg, 0.072 mmol) in anhydrous THF under Argon at 0°C. The resulting solution was warmed up to room temperature for 1 h and heated to reflux overnight. The reaction mixture was cooled to 0°C again and a solution of Rochelle salt was added cautiously. After being stirred for 1 h, the mixture was extracted with CH 2 Cl 2 (3 ϫ 20 ml). The combined extracts were washed with brine and dried over anhydrous Na 2 SO 4 . After filtration and concentration, the crude product was purified by flash chromatography ( Dehydroxylanandamide. Arachidonic acid of 5 ml (31 mg, 0.1 mmol) in CH 2 Cl 2 was added to a solution containing ethylamine in THF (2 M, 0.1 ml), Et 3 N (0.3 mmol, 42 l) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.2 mmol, 38 mg) successively under argon at 0°C. The reaction mixture was stirred at room temperature overnight and then diluted with CH 2 Cl 2 (20 ml). The diluted mixture was washed successively with 2 M HCl (10 ml) and water. The product was saturated with NaHCO 3 and brine, and it was then dried over anhydrous Na 2 OS 4 . After filtration and concentration, the crude product was purified by flash chromatography (CHCl 3 :MeOH: NH 4 OH ϭ 98:1.9:0.1) to give dehydroxylanandamide (dehydroxyl-AEA; 23.7 mg, 71.6%) as clear oil.
1 H NMR (CDCl 3 , 400 MHz) ␦ 5.36 (m, 8H), 3.27 (m, 2H), 2.82 (m, 6H), 2.10 (m, 6H), 1.71 (m, 2H), 1.31 (m, 6H), 1.13 (t, J ϭ 7.2 Hz, 3H), 0.88 (t, J ϭ 6.4 Hz, 3H); 13 C NMR (CDCl 3 , 100 MHz) ␦ 172. 6, 130.5, 129.2, 128.7, 128.6, 128.23, 128.20, 127.9, 127.5, 36.1, 34.3, 31.5, 29.3, 27.2, 26.7, 25.6, 25.5, 22.6, 14.9, 14 .0; ESI-MS 332.3 (M ϩ ϩ 1); HRMS (ES ϩ ) calculated for C 22 H 38 NO, 332.2953; found, 332.2960. Didesoxy-THC. Didesoxy-THC was synthesized as described previously (Xiong et al., 2011) .
Data analysis
Statistical analysis of concentration-response data was performed using the nonlinear curve-fitting program (Prism 5.0). Data were fit using the Hill equation Hill Slope) where I is the current amplitude activated by a given concentration of agonist ([Agonist]), I max is the maximum response of the cell, and EC 50 is the concentration eliciting a half-maximal response. Data were statistically compared by the unpaired t test, or ANOVA, as noted. Average values are expressed as mean Ϯ SE.
Results
AEA potentiation of native and recombinant GlyRs
While AEA did not trigger detectable current even at high concentrations (Ͼ30 M), AEA at 1 M increased the magnitude of currents activated by a 2% maximal effective (EC 2 ) concentration of Gly in cultured spinal neurons and in HEK-293 cells expressing human ␣1 GlyRs (Fig. 1 B) . AEA was always applied after stable I Gly as basal current was achieved. When AEA was applied continuously with intermittent Gly applications every minute, the potentiation gradually increased over the first few minutes of sustained AEA exposure. The maximal magnitude of potentiation was reached after 5 min of sustained AEA application in both spinal neurons and in HEK-293 cells expressing the ␣1 homomeric and ␣1␤1 heteromeric GlyRs (Fig. 1C) . Consistent with a previous study showing that the ␣1 subunits were abundantly expressed in cultured spinal neurons (Tapia and Aguayo, 1998) , the magnitudes of AEA potentiation of I Gly appeared similar between spinal neurons and HEK-293 cells expressing the ␣1 subunits. For instance, the average percentage potentiation of I Gly induced by 1 M AEA was 86 Ϯ 24% (n ϭ 6) in spinal neurons and 97 Ϯ 16% (n ϭ 7) or 85 Ϯ 12% (n ϭ 6) in HEK-293 cells expressing the ␣1 or ␣1␤1 subunits. These values were significantly higher than the initial values observed after 1 min of AEA exposure, 6 Ϯ 6% (neurons) and 3 Ϯ 1% (HEK-293 cells) ( p Ͻ 0.05, one-way ANOVA followed by Dunnett's test comparing the last response to the response in the first minute).
In addition to activating CB 1 and CB 2 receptors, AEA also activates vanilloid receptors in neurons (Pertwee, 2000; Smart et al., 2000; Ross, 2003) . To determine whether AEA potentiates I Gly through activating CB 1 , CB 2 and vanilloid receptors, we tested the effects of specific antagonists of these receptors on AEAinduced potentiation of I Gly in cultured spinal neurons (Fig. 1 D) . Selective antagonists of CB 1 (AM251, 1 M), CB 2 (SR144528, 1 M) and vanilloid (capsazepine, 2 M) receptors did not significantly alter the AEA-induced potentiation of I Gly in cultured spinal neurons (AM251, p ϭ 0.84; SR144528, p ϭ 0.97; Capsazepine, p ϭ 0.56 compared with vehicle solution using one-way ANOVA . S296 is critical for AEA potentiation of ␣1 and ␣3 GlyRs. A, Differential AEA potentiation of I Gly activated by EC 2 concentrations of Gly (10 M for the ␣1 subunit, 20 M for the ␣2 subunit and 100 M for the ␣3 subunit) in HEK-293 cells. The AEA (10 M) was applied before agonist, and applied continuously for 5 min with intermittent 10 s Gly ϩ AEA applications as shown in Figure 1 B . B, Average potentiation by AEA of I Gly in different HEK-293 cells expressing ␣1, ␣2 or ␣3 GlyRs (n ϭ 6 -7). ***p Ͻ 0.001, ␣2 vs ␣1 or ␣3, one-way ANOVA followed by Dunnett's post hoc test. C, Amino acid alignment of the TM3 region flanking S296 (␣1) or equivalent residues in the ␣2 (A303) and ␣3 (S307) subunits. D, The effect of AEA (10 M) on I Gly activated by an EC 2 concentration of Gly (10 M) in cells expressing the S296A mutant and wild-type ␣1 GlyRs. E, The effects of AEA (10 M) on I Gly activated by the EC 2 concentration of Gly (100 M) in cells expressing the S307A mutant and wild-type ␣3 GlyRs. F, The effects of AEA (10 M) on I Gly activated by the EC 2 concentration of Gly (20 M) in cells expressing the A303S mutant and wild-type ␣2 GlyRs. **p Ͻ 0.01, unpaired t test.
followed by Dunnett's post hoc test), suggesting that AEA potentiation of native GlyRs does not depend on the CB 1 , CB 2 and vanilloid receptors. AEA enhanced the peak amplitude of I Gly in a concentration-dependent manner in spinal neurons and HEK-293 cells expressing the homomeric GlyR ␣1 subunit (Fig. 1 E) . The magnitudes of average percentage potentiation induced by 1, 3, 10, and 30 M AEA were 91 Ϯ 9%, 311 Ϯ 86%, 712 Ϯ 96%, and 824 Ϯ 278%, respectively, in HEK-293 cells, and 79 Ϯ 19%, 236 Ϯ 52%, 636 Ϯ 87% and 800 Ϯ 71%, respectively, in spinal neurons. The EC 50 values for AEA potentiation were 4.2 Ϯ 1.95 M in HEK-293 cells expressing ␣1 homomeric GlyRs and 5.5 Ϯ 2.0 M in spinal neurons. These values are not significantly different from one another ( p ϭ 0.85, unpaired t test, n ϭ 5-7). AEA potentiation depended on the Gly concentration (Fig. 1 F) . With increasing Gly concentrations, the AEA potentiation was decreased. For example, the magnitude of average percentage potentiation induced by 10 M AEA was 712 Ϯ 96% in the presence of Gly at 10 M in HEK-293 cells expressing the ␣1 subunit, while the magnitude of AEA potentiation was 102 Ϯ 49% or 24 Ϯ 6% when Gly concentrations were increased up to 30 and 100 M.
S296
: essential for AEA potentiation of the ␣1 and ␣3 subunit-containing GlyRs Next we asked whether or not three distinct ␣ subunits of GlyRs are differentially sensitive to AEA-induced potentiation. We first determined the EC 50 values from the Gly concentration-response curves in HEK-293 cells transfected with ␣1 ␣2 or ␣3 subunits of GlyR. The EC 50 values for Gly were 64 Ϯ 13 M for the ␣1 subunit, 128 Ϯ 10 M for the ␣2 subunit and 354 Ϯ 29 M for the ␣3 subunit. These values were significantly different from one another ( p Ͻ 0.05, one-way ANOVA with Dunnett's post hoc test against ␣1, n ϭ 6 -11). We then examined the effect of AEA on I Gly activated by EC 2 concentrations of Gly in HEK-293 cells expressing each subtype of GlyRs. While the ␣1 and ␣3 GlyR subunits appeared to be equally sensitive to AEA-induced potentiation, the ␣2 GlyR subunits were less sensitive to AEA when expressed in HEK-293 cells ( Fig. 2A) . The magnitudes of average percentage potentiation induced by 10 M AEA were 695 Ϯ 76% and 730 Ϯ 58% in cells expressing the ␣1 and ␣3 subunits. In contrast, the magnitude of AEA enhancement of receptors containing the ␣2 subunit (127 Ϯ 37%) was significantly lower than that of receptors containing the ␣1 and ␣3 subunits (p Ͻ 0.001 compared with ␣1 or ␣3, one-way ANOVA with Dunnett's post hoc test, n ϭ 6) (Fig. 2B) . A recent study from our laboratory has suggested that the S296 residue of the ␣1 and the S307 of the ␣3 GlyRs are critical for the THC-induced potentiation of I Gly (Xiong et al., 2011) . We next tested whether the S296/S307 residue is also critical for differential AEA sensitivity of GlyR subunits. The serine (S) at 296 and 307 in the TM3 is conserved between the ␣1 and ␣3 subunits, respectively. In contrast, the equivalent residue at 303 of the ␣2 subunit is Alanine (A), which is the only residue throughout the entire 4 TMs of the ␣2 subunit that differs from a corresponding residue identical between the ␣1 (S296) and ␣3 (S307) subunits ( 2C). The S296A mutation in the ␣1 subunit significantly reduced the magnitude of AEA-induced potentiation from 695 Ϯ 77% to 131 Ϯ 41% (Fig. 2 D, p Ͻ 0.01, n ϭ 7, unpaired t test). Similarly, The S307A mutation in the ␣3 subunit also significantly reduced AEA potentiation from 731 Ϯ 58% to 249 Ϯ 48% (Fig. 2 E , p Ͻ 0.01, n ϭ 6, unpaired t test). Conversely, substitution of the corresponding residue, A303, of the ␣2 subunit with serine significantly increased the magnitude of AEAinduced potentiation from 127 Ϯ 37% to 580 Ϯ 110% (Fig. 2 F , p Ͻ 0.01, n ϭ 6, unpaired t test). The S296A mutation in the ␣1 subunit did not significantly affect the Gly EC 50 value (Fig. 3A , 64 Ϯ 13 M vs 66 Ϯ 7 M, p ϭ 0.67, n ϭ 6, unpaired t test) and maximal current density (MCD) induced by a maximally efficacious Gly concentration (3 mM) (Fig. 3B , 912 Ϯ 153 pA/pF vs 906 Ϯ 147 pA/pF, p ϭ 0.67, n ϭ 6, unpaired t test). Similarly, neither the A303S mutation of ␣2 GlyR nor the S307A mutation of ␣3 GlyR significantly changed the Gly EC 50 value and MCD ( Fig. 3C-F ) . We also examined the inhibition of I Gly by strychnine, a selective glycine receptor antagonist, in cells expressing the S296A mutant and WT ␣1 receptors. The S296A mutation in the ␣1 subunit did not significantly affect the strychnine (100 nM)-induced inhibiting effect on I Gly activated by Gly at an EC 50 concentration (78 Ϯ 9% vs 81 Ϯ 13%, n ϭ 7, p Ͼ 0.2).
S296 selectively contributes to sustained AEA application-induced potentiation
The maximal magnitude of AEA potentiation of GlyRs reported here was significantly higher than what we and others described in previous studies in which AEA was simultaneously coapplied with agonists (Hejazi et al., 2006; Ahrens et al., 2009; Yevenes and Zeilhofer, 2011a) . One possibility that might account for this discrepancy is that distinct molecular processes are involved in AEA potentiation of GlyRs with and without sustained AEA incubation. To test this hypothesis, we first compared the potentiation of three GlyR subunits induced by sustained AEA application and simultaneous AEA application. Unlike the result obtained from sustained THC and AEA incubation (Fig. 4 A) , there was no significant difference in either simultaneous THC or simultaneous AEAinduced potentiation of the ␣1, ␣2 and ␣3 subunits expressed in HEK-293 cells (Fig. 4 B, p Ͼ 0.2). Next we compared the role of the S296A mutation in both sustained and simultaneous AEA incubation-induced potentiation of the ␣1 subunit. While the S296A mutation significantly inhibited AEA potentiation after 5 min sustained incubation (695 Ϯ 77% vs 131 Ϯ 41%, p Ͻ 0.001, n ϭ 5-6, unpaired t test), the S296A mutant and WT receptors did not significantly differ in their sensitivity to AEA (10 M)-induced potentiation when simultaneously applied only with Gly (Fig. 4C,D , 108 Ϯ 15% vs 99 Ϯ 20%). A very recent study has suggested that the G254 residue in TM2 of the ␣1 GlyR regulates the receptor's sensitivity to the endocannabinoid 2-arachidonoylglycerol when these compounds are coapplied with agonist (Yevenes and Zeilhofer, 2011a) . In view of this, we examined the effect of the G254A mutation (Fig. 4E ) on the maximal potentiating effect on I Gly induced by AEA after 5 min sustained incubation with intermittent application of Gly. The G254A mutation did not significantly alter the sustained AEA incubation-induced potentiation of I Gly (Fig. 4F , 695 Ϯ 77% vs 597 Ϯ 77%, p ϭ 0.40, n ϭ 5, unpaired t test).
Chemical modification of AEA: critical role of hydroxyl/ oxygen groups of AEA Several phytocannabinoids such as THC and cannabidiol (CBD) can potentiate GlyRs (Hejazi et al., 2006; Yang et al., 2008; Ahrens et al., 2009) . We next examined the influence of the S296A mutation on THC, CBD and HU210-induced potentiation of the ␣1 GlyR (Fig. 5A) . The S296A mutation significantly reduced the potentiation of I Gly induced by THC (1 M, p Ͻ 0.001, n ϭ 8, unpaired t test), CBD (1 M, p Ͻ 0.05, n ϭ 6, unpaired t test) and HU210 (1 M, p Ͻ 0.001, n ϭ 6, unpaired t test). Removal of both hydroxyl and oxygen groups from THC resulted in a new compound, didesoxy-THC, which substantially reduced THCinduced potentiation of the ␣1 GlyR (Xiong et al., 2011) . While AEA and THC are structurally different, both compounds are potent agonists of CB 1 receptors and likely bind to a similar molecular pocket of the receptor (Pertwee, 2008) . We proposed that exogenous and endogenous cannabinoids interact with GlyRs via a similar molecular process. To test this hypothesis, we removed sequentially the hydroxyl or oxygen groups from AEA (Fig. 5B) . The compounds with removal of hydroxyl (dehydroxyl-AEA) or oxygen group (desoxy-AEA) showed a reduced efficacy in potentiating I Gly in receptors containing the ␣1 subunit (Fig. 5B) . The reduction in the efficacy of AEA potentiation was more obvious with removal of the oxygen group from AEA (desoxy-AEA). To determine whether THC and AEA may share common interacting sites on the GlyRs, we cross-examined the effect of desoxy-AEA and didesoxy-THC on THC and AEA-induced potentiation of I Gly in cells expressing the ␣1 subunits. Desoxy-AEA at 3 M inhibited the magnitude of AEA and THC-induced potentiation in an apparently competitive manner (Fig. 5C,D) . Both concentration-response curves of AEA and THC-induced potentiation were shifted in parallel to the right in the presence of desoxy-AEA. Similarly, didesoxy-THC inhibited AEA and THC-induced potentiation in a competitive manner that was also observed in desoxy-AEA (Fig. 5 E, F ) .
S296 is not involved in AEA-induced inhibition of 5-HT 3A receptors
There is strong evidence that AEA can inhibit serotonin-gated ion channels (5-HT 3A R) through a direct interaction (Fan, 1995; Barann et al., 2002; Oz et al., 2002; Xiong et al., 2008) . The 5-HT 3A R and GlyR are both members of the Cys-loop LGIC superfamily and thus share a high level of amino acid sequence homology, especially within the transmembrane domains. For instance, the S296 residue is conserved between 5-HT 3A R and GlyRs (Fig. 6 A) . In view of this, we explored the role of S296 in the sensitivity of 5-HT 3A Rs to AEA (Fig. 6 A) . Consistent with a previous observation (Xiong et al., 2008) , incubation of AEA (0.1 M) for 5 min produced gradually developing inhibition of 5-HT (30 M)-activated currents in HEK-293 cells expressing the WT 5-HT 3A receptors (Fig. 6 B) . In these cells, the AEA-induced inhibition of I 5-HT reached a maximum after a continuous exposure to 0.1 M AEA for 5 min. Even though AEA produced different types of modulation (inhibition vs potentiation) of 5-HT 3A Rs and GlyRs, the time courses of AEA modulation of both receptors appeared similar. However, the S296A mutation of the 5-HT 3A receptors did not significantly alter the AEA-induced inhibition of 5-HT-activated current (Fig. 6C , p ϭ 0.45, n ϭ 6 -10, Two-way ANOVA). This finding suggests that the S296A residue selectively regulates AEA modulation of GlyRs but not 5-HT 3A Rs. Although the S296 residue is conserved in the amino acid sequence of GlyR and 5-HT 3A R, molecular modeling at the two dimensional level revealed that the orientation of S296 of GlyR differs from that of 5-HT 3A R. For instance, S296 of GlyR is facing outside of the ion channel protein and lipid interface, a supposed docking site for AEA (Fig. 6 D) . In contrast, S296 of 5-HT 3A receptor is hiding inside of the channel protein and away from lipid-protein interfaces (Fig. 6 E) . Both S296 residues do not overlap (Fig. 6 F) .
Molecular docking of AEA and THC onto the ␣1 GlyR Molecular modeling of AEA/THC and the TM1-4 of the GlyR␣1 subunit revealed that the hydroxyl groups (in red, Fig. 7 A, B) of AEA and THC likely interact with the GlyR in a location between TM3 and TM4 (Fig. 7C-F ) . The predicted interaction of AEA and THC with TM3 may occur via a hydrogen bond between the hydroxyl groups in AEA and the side chain of S296. AEA is well situated in the vicinity of TM3-4 of the ␣1 subunit in the monomer and pentamer. The hydrogen bonding interaction between AEA/THC and the side chain of S296 can be clearly seen by the close contact of their hydroxyl groups. With the exception of this hydrogen bond, the remaining interactions between AEA/THC and GlyR are likely to be via van der Waals forces. 
Discussion
The data presented in this study suggest that both exogenous and endogenous cannabinoids potentiate GlyRs based on a common molecular process. Like THC, AEA-induced potentiation of I Gly developed gradually, and required sustained incubation. A similar finding was described in recent studies of the exogenous cannabinoid-induced potentiation of I Gly in both spinal neurons and in cells expressing recombinant GlyRs (Xiong et al., 2011) . This feature is also associated with cannabinoid modulation of a number of the Cys-loop LGICs. For instance, AEA inhibits 5-HT 3A Rs and nAChRs in a timedependent manner, which required sustained incubation of AEA (Fan, 1995; Spivak et al., 2007) . AEA differentially modulated different GlyR subunits in a manner similar to that of THC (Xiong et al., 2011) . The amino acid residue serine at 296 was found to be critical for both AEA and THC-induced potentiating effect on I Gly in cells expressing the ␣1 and ␣3 subunits. Conversion of the equivalent residue, alanine, in the ␣2 subunit to serine rescued the sensitivity of the GlyRs to AEA and THC potentiation. The hydroxyl/oxygen groups appeared to be important functional groups for both AEA and THC in potentiating I Gly . Finally, deletion of these groups resulted in reduction in the efficacy of AEA and THC potentiation. Desoxy-AEA and didesoxy-THC competitively inhibited both AEA and THC-induced potentiation of GlyRs in a similar manner. It is worth mentioning that different protocols for AEA application (sustained application vs simultaneous application with agonists) could cause several notable discrepancies between this study and previous reports. First, the maximal magnitude of AEA potentiation of the ␣1 GlyRs was estimated to be 80 -100% by 1 M AEA in previous studies when AEA was applied only simultaneously with Gly (Hejazi et al., 2006; Yang et al., 2008; Yevenes and Zeilhofer, 2011a ). In the current study the maximal potentiation of the ␣1 GlyRs was nearly 700 -800% when AEA was applied continuously for 5 min with intermittent supplication of Gly. Second, because of a substantial change in E max of AEA potentiation and maximally efficacious concentration of AEA, the EC 50 value of AEA potentiation of GlyRs increased from a range of 38 -110 nM range described in previous studies to 4.2 M observed in the current study. Third, AEA did not significantly alter I Gly in HEK-293 cells expressing the ␣3 GlyRs in a previous study (Yang et al., 2008; Yevenes and Zeilhofer, 2011a) , whereas AEA significantly potentiated the ␣3 GlyRs as reported in this study, and it is likely that the larger effect of sustained AEA application explains this difference. Finally, the data presented in this study suggest that two distinct molecular processes may be involved in the potentiating effect on I Gly induced by sustained AEA application with intermittent application of Gly and simultaneous AEA application with Gly. The S296A mutation appeared to selectively contribute to the mechanism underlying sustained cannabinoidinduced potentiation of the ␣1 and ␣3 subunits. The molecular determinants for simultaneous AEA and THC-induced potentiation remain elusive. There is no differential sensitivity of GlyR subunits to simultaneous AEA and THC-induced potentiation.
The S296 residue appeared critical for increased sensitivity of the ␣1 and ␣3 GlyRs to the AEA-induced potentiation of I Gly compared with the ␣2 subunit. Conversion of this amino acid residue to the corresponding alanine in the ␣2 subunit selectively altered the receptor's sensitivity to AEA potentiation without significantly changing the EC 50 value for Gly or the expression level of receptor protein. The precise molecular mechanism by which S296 interacts with AEA remains to be determined. However, one prominent possibility is that S296 is involved in a hydrogen bonding interaction between AEA and GlyR protein. The most notable difference between the structures of alanine (A) and serine (S) is that one of the methylic hydrogens in the serine side chain is substituted by a hydroxyl group. This allows serine to form a hydrogen bond with potential ligands/modulators. Consistent with this, molecular docking of the GlyR-AEA system suggests a high probability binding mode, perhaps via a possible hydrogen bonding interaction between AEA and the hydroxyl group of the side chains of S296. This hypothesis fits well with a recent study showing that the polarity of the amino acid residue at 296 or the equivalent position in both ␣1 and ␣3 GlyRs is correlated with the magnitude of THC-induced potentiation of I Gly (Xiong et al., 2011) . Alternatively, the S296 residue may play a role in sensing or stabilizing the AEA-induced conformational change that occurs at protein-lipid interface since S296 is thought to be located in the membrane-embedded portion of TM3 of GlyR proteins. This hypothesis is favored by the slow onset of AEA modulation of GlyRs as well as other LGICs, suggesting that AEA may have difficulty in molding itself to the lipid face of receptor transmembrane domains. Consistent with this hypothesis, it has been suggested that the lipid bilayer plays a central role in determining the location and orientation of AEA with respect to membrane targeted proteins (Di Marzo et al., 1998) . It should be noted, however, that other residues that differ between the ␣1/␣3 and ␣2 subunits likely contribute to differential AEA potentiation of GlyRs. Both S296A and S307A mutations in the ␣1 and ␣3 subunits only partially inhibited the AEA potentiation. While the expression level of the ␣2 subunit is significantly reduced after 1 week in cultured neurons, the ␣1 and ␣3 subunits are highly expressed in embryonic spinal cord neurons after a prolonged period (1 or 2 weeks) of in vitro growth (Aguayo et al., 2004) . This expression pattern (high expression of the ␣1 and ␣3 subunits and low expression of the ␣2 subunits) in cultured spinal neurons fits well with what we found in this study. The sensitivity of GlyRs to AEA in native spinal neurons was similar to that of the ␣1 and ␣3 subunits expressed in HEK-293 cells. Subunit-specific modulation of GlyRs has been described for a number of allosteric modulators of GlyRs (Yevenes and Zeilhofer, 2011b) . The ␣1 GlyRs are more sensitive to ethanolinduced potentiation compared with ␣2 and ␣3 GlyRs (Mascia et al., 1996; Perkins et al., 2008; Yevenes et al., 2010) . Neurosteroids are also found to potentiate the GlyRs in a subunit-specific manner (Maksay et al., 2001) . There is strong evidence that distinct molecular sites contribute to allosteric modulation of GlyRs by different substances (Lobo and Harris, 2005; Harris et al., 2008; Yevenes and Zeilhofer, 2011a) . It is interesting to note that the S296 is not involved in AEA modulation of 5-HT 3A Rs even though the S296 residue is conserved between the ␣1GlyRs and 5-HT 3A Rs. Such a dramatic difference can be explained by the molecular modeling of the surrounding vicinity of S296 of the two receptors, which reveals different orientations of the S296 in its relationship with subunit interfaces and protein lipid interfaces.
AEA's binding affinity (K i ) for CB 1 and CB 2 receptors are 61-543 nM and 279 -1940 nM (Pertwee, 2000) . AEA at the concentration range (1 M) used in this study will likely activate CB 1 and CB 2 receptors in cultured spinal neurons. These receptors are unlikely to contribute to the effect of AEA on I Gly in this study because selective antagonists of CB 1 and CB 2 receptors did not prevent the AEA potentiation of I Gly in spinal neurons. Direct modulation of GlyRs by AEA through CB 1 -independent mechanism was also reported in a previous study (Lozovaya et al., 2005) . It must be noted that AEA was found to inhibit I Gly in the presence of CB 1 /CB 2 receptor antagonists in hippocampal neurons (Lozovaya et al., 2005) . One possible explanation for the different effects of AEA on I Gly could be that different GlyR subunits and signal transduction pathways that exist in different neurons could also contribute to the apparently discrepant effects. Alternatively, the apparent discrepancy may be partially caused by differences in experimental design. For example, different concentrations of Gly were used in the two studies. We and others observed that the magnitude of AEA-induced potentiation of I Gly depended on Gly concentrations (Hejazi et al., 2006; Yang et al., 2008) . The maximal AEA potentiation was observed when the lowest concentrations of Gly were applied. The extent of the AEA-induced potentiation of ␣1 GlyRs could be reduced substantially when the concentrations of Gly were Ͼ100 M as used in the Lozovaya et al. (2005) study. Thus other factors, such as receptor desensitization, must be considered when trying to explain the inhibition observed by Lozovaya et al. (2005) .
The ␣1 GlyR is expressed mainly in the spinal motor neurons (Legendre, 2001; Lynch, 2004) . Humans and rodents carrying certain single amino acid polymorphisms/mutations on the ␣1 GlyRs at postsynaptic sites have severe deficiencies in neuromotor activity (Shiang et al., 1993 (Shiang et al., , 1995 . The ␣3 GlyRs are abundantly expressed in the adult spinal cord dorsal horn where these receptors critically regulate inflammatory pain sensation (Harvey et al., 2004) . Some reports showed that AEA-induced antinociception can occur through a CB 1 -independent pathway (Adams et al., 1998; Smith et al., 1998; Vivian et al., 1998; Zimmer et al., 1999; Di Marzo et al., 2000) . Future studies are awaited for exploring in vivo consequences of AEA potentiation of GlyRs.
